Plotnik, Meir
Wagner, Joanne M.
Adusumilli, Gautam
Gottlieb, Amihai
Naismith, Robert T.
Funding for this research was provided by:
National Institutes of Health (K12 HD055931, CO6 RR020092)
National Multiple Sclerosis Society (PP1940)
National Center for Research Resources (UL1 RR024992)
Article History
Received: 19 December 2019
Accepted: 22 June 2020
First Online: 24 July 2020
Competing interests
: RTN has received honorarium for speaking/consulting from Alexion, Alkermes, Biogen, Celgene, EMD Serono, Genentech, Genzyme, Novartis, Alexion, TG Therapeutics, Viela Bio. All other authors declare no competing interests.